Related Experiment Videos
Controversies in the management of Parkinson's disease
1Department of Medicine, University of British Columbia, Health Sciences Centre Hospital, Vancouver, Canada.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The cardiovascular effects of bromocriptine in Parkinsonism.
British journal of clinical pharmacology·2012
The role of the Lewy body in idiopathic Parkinsonism.
Parkinsonism & related disorders·2008
German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia - Longitudinal observations.
Parkinsonism & related disorders·2008
The natural history of neurological manganism over 18 years.
Parkinsonism & related disorders·2006
Efficacy and Safety of DL-3-n-Butylphthalide in Spinocerebellar Ataxia Type 3.
Movement disorders : official journal of the Movement Disorder Society·2026
A De Novo 16p13.3 Triplication Underlying Early-Onset Complex Neurodegeneration.
Movement disorders : official journal of the Movement Disorder Society·2026
Novel and Emerging Therapies for Childhood-Onset Movement Disorders.
Movement disorders : official journal of the Movement Disorder Society·2026
Selectivity Filter KCND3 Variant Causes Spinocerebellar Ataxia 19/22 and KV4.3 Functional Loss.
Movement disorders : official journal of the Movement Disorder Society·2026
Longitudinal Iron Changes in the Substantia Nigra of Early-Stage Parkinson's Disease.
Movement disorders : official journal of the Movement Disorder Society·2026
Spatiotemporal Tau Accumulation and its Clinical Impact on Progressive Supranuclear Palsy: Longitudinal Florzolotau (18F) Positron Emission Tomography.
Movement disorders : official journal of the Movement Disorder Society·2026
Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.
Journal of immunology (Baltimore, Md. : 1950)·2026
Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.
Handbook of experimental pharmacology·2026
Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?
The Journal of clinical endocrinology and metabolism·2026
Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review.
Immunity, inflammation and disease·2026